JAZZ Jazz Pharmaceuticals plc

+1.95  (1%)
Previous Close 150.10
Open 151.51
Price To book 4.54
Market Cap 9.13B
Shares 60,028,000
Volume 286,833
Short Ratio 1.84
Av. Daily Volume 531,402

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL received October 11, 2010.
Phase 2 enrollment initiation announced February 8, 2017.
Excessive Sleepiness in Parkinson's Disease
Phase 2/3 positive data released April 24, 2017. sNDA filing due 4Q 2017.
Pediatric narcolepsy patients with cataplexy
Phase 3 data released March 20, 2017 - primary endpoints met.
Excessive sleepiness associated with obstructive sleep apnea
Phase 3 data released April 26, 2017. NDA to be filed late 2017.
Excessive sleepiness associated with narcolepsy
Phase 3 trial initiated 3Q 2016.
VOD in high-risk patients following hematopoietic stem cell transplantation
Announced April 3, 2017 that rolling NDA submission has been completed. Priority review has been requested.
Acute myeloid leukemia

Latest News

  1. Jazz Pharmaceuticals Announces Webcast Discussion of Data to be Presented at APSS
  2. Jazz Pharmaceuticals to Present Phase 3 Data on JZP-110, an Investigational Treatment for Excessive Sleepiness in Patients with Narcolepsy and with Obstructive Sleep Apnea, During 31st Annual SLEEP Meeting
  3. BioLineRx Makes Regulatory Submission for Trial of BL-8040
  4. ETFs with exposure to Jazz Pharmaceuticals Plc : May 22, 2017
  5. 3 Value Stocks for Ambitious Investors
  6. Jazz Pharmaceuticals Plc :JAZZ-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017
  7. Jazz Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : JAZZ-US : May 18, 2017
  8. Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences
  9. Edited Transcript of JAZZ earnings conference call or presentation 9-May-17 8:30pm GMT
  10. 4 of the Cheapest Biotech Stocks in the World
  11. Jazz Pharmaceuticals (JAZZ) Misses Q1 Earnings & Sales
  12. Jazz misses Street 1Q forecasts
  13. Jazz Pharma Reports Lagging First-Quarter Sales, Profits
  14. Jazz Pharmaceuticals Announces First Quarter 2017 Financial Results
  15. Investor Network: Jazz Pharmaceuticals Plc to Host Earnings Call
  16. Allergan's Q1 Sales Expected To Slip As Jazz Pharma Outperforms
  17. 4 Medical Stocks That Could Be Big Winners Next Week
  18. Jazz Pharma (JAZZ) Q1 Earnings: Stock Likely to Disappoint?
  19. 3 Top Biotech Stocks to Buy Now
  20. Jazz Pharmaceuticals Announces Positive Results from the Phase 3 TONES 2 Study of JZP-110 in Narcolepsy Patients with Excessive Sleepiness